Characteristics of bremsstrahlung in electron beams

Nontarget and Out-of-Field Doses from Electron Beam Radiotherapy

In clinical radiotherapy, the most important aspects are the dose distribution in the target volume and healthy organs, including out-of-field doses in the body. Compared to photon beam radiation, dose distribution in electron beam radiotherapy has received much less attention, mainly due to the limited range of electrons in tissues. However, given the growing use of electron intraoperative radiotherapy and FLASH, further study is needed. Therefore, in this study, we determined out-of-field doses from an electron beam in a phantom model using two dosimetric detectors (diode E and cylindrical Farmer-type ionizing chamber) for electron energies of 6 MeV, 9 MeV and 12 MeV. We found a clear decrease in out-of-field doses as the distance from the field edge and depth increased. The out-of-field doses measured with the diode E were lower than those measured with the Farmer-type ionization chamber at each depth and for each electron energy level. The out-of-field doses increased when higher energy megavoltage electron beams were used (except for 9 MeV). The out-of-field doses at shallow depths (1 or 2 cm) declined rapidly up to a distance of 3 cm from the field edge. This study provides valuable data on the deposition of radiation energy from electron beams outside the irradiation field.

Tungsten filled 3D printed field shaping devices for electron beam radiation therapy

Purpose

Electron radiotherapy is a labor-intensive treatment option that is complicated by the need for field shaping blocks. These blocks are typically made from casting Cerrobend alloys containing lead and cadmium. This is a highly toxic process with limited precision. This work aims to provide streamlined and more precise electron radiotherapy by 3D using printing techniques.

Methods

The 3D printed electron cutout consists of plastic shells filled with 2 mm diameter tungsten ball bearings. Five clinical Cerrobend defined field were compared to the planned fields by measuring the light field edge when mounted in the electron applicator on a linear accelerator. The dose transmitted through the 3D printed and Cerrobend cutouts was measured using an IC profiler ion chamber array with 6 MeV and 16 MeV beams. Dose profiles from the treatment planning system were also compared to the measured dose profiles. Centering and full width half maximum (FWHM) metrics were taken directly from the profiler software.

Results

The transmission of a 16MeV beam through a 12 mm thick layer of tungsten ball bearings agreed within 1% of a 15 mm thick Cerrobend block (measured with an ion chamber array). The radiation fields shaped by ball bearing filled 3D printed cutout were centered within 0.4 mm of the planned outline, whereas the Cerrobend cutout fields had shift errors of 1–3 mm, and shape errors of 0.5–2 mm. The average shift of Cerrobend cutouts was 2.3 mm compared to the planned fields (n = 5). Beam penumbra of the 3D printed cutouts was found to be equivalent to the 15 mm thick Cerrobend cutout. The beam profiles agreed within 1.2% across the whole 30 cm profile widths.

Conclusions

This study demonstrates that with a proper quality assurance procedure, 3D-printed cutouts can provide more accurate electron radiotherapy with reduced toxicity compared to traditional Cerrobend methods.

Experimental validatıon of peripheral dose distribution of electron beams for eclipse electron Monte Carlo algorithm

Aim

The accuracy of two calculation algorithms of the Varian Eclipse treatment planning system (TPS), the electron Monte Carlo algorithm (eMC) and general Gaussian pencil beam algorithm (GGPB) for calculating peripheral dose distribution of electron beams was investigated.

Methods

Peripheral dose measurements were carried out for 6, 9, 12, 15, 18 and 22 MeV electron beams using parallel plate ionisation chamber and EBT3 film in the slab phantom. Measurements were performed for 6×6, 10×10 and 25×25 cm2 cone sizes at dmax of each energy up to 20 cm beyond the field edges. The measured and TPS calculated data were compared.

Results

The TPS underestimated the out-of-field doses. The difference between measured and calculated doses increase with the cone size. For ionisation chamber measurement, the largest deviation between calculated and measured doses is <4·29% using the eMC, but can increase up to 8·72% of the distribution using GGPB. For film measurement, the minimum gamma analysis passing rates between measured and calculated dose distributions for all field sizes and energies used in this study were 91·2 and 74·7% for eMC and GGPB, respectively.

Findings

The use of GGPB for planning large field treatments with 6 MeV could lead to inaccuracies of clinical significance.

Experimental assessment of out-of-field dose components in high energy electron beams used in external beam radiotherapy

The purpose of this work was to experimentally investigate the out-of-field dose in a water phantom, with several high energy electron beams used in external beam radiotherapy (RT). The study was carried out for 6, 9, 12, and 18 MeV electron beams, on three different linear accelerators, each equipped with a specific applicator. Measurements were performed in a water phantom, at different depths, for different applicator sizes, and off-axis distances up to 70 cm from beam central axis (CAX). Thermoluminescent powder dosimeters (TLD-700) were used. For given cases, TLD measurements were compared to EBT3 films and parallel-plane ionization chamber measurements. Also, out-of-field doses at 10 cm depth, with and without applicator, were evaluated. With the Siemens applicators, a peak dose appears at about 12-15 cm out of the field edge, at 1 cm depth, for all field sizes and energies. For the Siemens Primus, with a 10 × 10 cm(²) applicator, this peak reaches 2.3%, 1%, 0.9% and 1.3% of the maximum central axis dose (Dmax) for 6, 9, 12 and 18 MeV electron beams, respectively. For the Siemens Oncor, with a 10 × 10 cm(²) applicator, this peak dose reaches 0.8%, 1%, 1.4%, and 1.6% of Dmax for 6, 9, 12, and 14 MeV, respectively, and these values increase with applicator size. For the Varian 2300C/D, the doses at 12.5 cm out of the field edge are 0.3%, 0.6%, 0.5%, and 1.1% of Dmax for 6, 9, 12, and 18 MeV, respectively, and increase with applicator size. No peak dose is evidenced for the Varian applicator for these energies. In summary, the out-of-field dose from electron beams increases with the beam energy and the applicator size, and decreases with the distance from the beam central axis and the depth in water. It also considerably depends on the applicator types. Our results can be of interest for the dose estimations delivered in healthy tissues outside the treatment field for the RT patient, as well as in studies exploring RT long-term effects.

Comparison between small radiation therapy electron beams collimated by Cerrobend and tubular applicators

The purpose of this study was to compare the dosimetric properties of small field electron beams shaped by circular Cerrobend blocks and stainless steel tubular applicators. Percentage depth dose curves, beam profiles, and output factors of small-size circular fields from 2 to 5 cm diameter, obtained either by tubular applicators and Cerrobend blocks, were measured for 6, 10, and 15 MeV electron beam energies. All measurements were performed using a PTW microDiamond 60019 premarket prototype. An overall similar behavior between the two collimating systems can be observed in terms of PDD and beam profiles. However, Cerrobend collimators produce a higher bremsstrahlung background under irradiation with high-energy electrons. In such irradiation condition, larger output factors are observed for tubular applicators. Similar dosimetric properties are observed using circular Cerrobend blocks and stainless steel tubular applicators at lower beam energies. However, Cerrobend collimators allow the delivery of specific beam shapes, conformed to the target area. On the other hand, in high-energy irradiation conditions, tubular applicators produce a lower bremsstrahlung contribution, leading to lower doses outside the target volume. In addition, the higher output factors observed at high energies for tubular applicators lead to reduced treatment times.

Feasibility study of patient positioning verification in electron beam radiotherapy with an electronic portal imaging device (EPID)

The purpose of this study is to demonstrate the feasibility of verification and documentation in electron beam radiotherapy using the photon contamination detected with an electronic portal imaging device. For investigation of electron beam verification with an EPID, the portal images are acquired irradiating two different tissue equivalent phantoms at different electron energies. Measurements were performed on an Elekta SL 25 linear accelerator with an amorphous-Si electronic portal imaging device (EPID: iViewGT, Elekta Oncology Systems, Crawley, UK). As a measure of EPID image quality contrast (CR) and signal-to-noise ratio (SNR) are determined. For characterisation of the imaging of the EPID RW3 slabs and a Gammex 467 phantom with different material inserts are used. With increasing electron energy the intensity of photon contamination increases, yielding an increasing signal-to-noise ratio, but images are showing a decreasing contrast. As the signal-to-noise ratio saturates with increasing dose a minimum of 50 MUs is recommended. Even image quality depends on electron energy and diameter of the patient, the acquired results are mostly sufficient to assess the accuracy of beam positioning. In general, the online EPID acquisition has been demonstrated to be an effective electron beam verification and documentation method. The results are showing that this procedure can be recommended to be routinely and reliably done in patient treatment with electron beams.

A novel shielding scheme studied by the Monte Carlo method for electron beam radiotherapy

Lead that has been employed widely for shielding in electron beam radiotherapy can produce bremsstrahlung photons during the shielding process. A novel shielding scheme with a two-layer structure has been studied using a Monte Carlo method in order to reduce this bremsstrahlung effect. Compared with the conventional lead, the novel shielding scheme, comprised of a Styrene-Ethylene-Butylene-Styrene Block Co-polymer (SEBS) above and lead below, can efficiently reduce the generation of bremsstrahlung while providing better shielding for incident electrons. Therefore, this novel shielding scheme may play an important role in future applications.

Electron beam characteristics at extended source-to-surface distances for irregular cut-outs

Electron beam therapy is widely used in the management of cancers. The rapid dose fall-off and the short range of an electron beam enable the treatment of lesions close to the surface, while sparing the underlying tissues. In an extended source-to-surface (SSD) treatment with irregular field sizes defined by cerrobend cutouts, underdosage of the lateral tissue may occur due to reduced beam flatness and uniformity. To study the changes in the beam characteristics, the depth dose, beam profile, and isodose distributions were measured at different SSDs for regular 10 × 10 cm² and 15 × 15 cm² cone, and for irregular cutouts of field size 6.5 × 9 cm² and 11.5 × 15 cm² for beam energies ranging from 6 to 20 MeV. The PDD, beam flatness, symmetry and uniformity index were compared. For lower energy (6 MeV), there was no change in the depth of maximum dose (R100) as SSD increased, but for higher energy (20 MeV), the R₁₀₀ depth increased from 2 cm to 3 cm as SSD increased. This shows that as SSD increases there is an increase in the depth of the maximum dose for higher energy beams. There is a +7 mm shift in the R₁₀₀ depth when compared with regular and irregular field sizes. The symmetry was found to be within limits for all the field sizes as the treatment distance extended as per International Electro technical Commision (IEC) protocol. There was a loss of beam flatness for irregular fields and it was more pronounced for lower energies as compared with higher energies, so that the clinically useful isodose level (80% and 90%) width decreases with increase in SSD. This suggests that target coverage at extended SSD with irregular cut-outs may be inadequate unless relatively large fields are used.

Technical note: on cerrobend shielding for 18-22 MeV electron beams

The purpose of this study is to investigate (1) the depth at which the measurement of the block transmission factor should be made, and (2) the level of the transmission of 18 and 22 MeV electron beams through conventional Cerrobend. We measured the block transmission in water phantom as ionization profiles across the beam and as ionization distributions along the central axis of the beam for 18 and 22 MeV electron beams, for cone sizes ranging from 6 x 10 cm2 to 25 x 25 cm2. In our analysis, we separated the bremsstrahlung component produced in the Cerrobend block from the component originating in the head in the transmitted dose under the standard Cerrobend block. The block transmission for both beam energies and cone sizes was maximum on the central axis of the beam at depths between 0.4 and 0.7 cm. For the 18 MeV beam, the maximum transmission was 6.2% for the 6 x 10 cm2 cone, and 7.4% for the 25 x 25 cm2 cone. For the 22 MeV beam, it was 9.5% for the 6 x 10 cm2 cone, and 11.3% for the 25 x 25 cm2 cone. For the 22 MeV beam and 15 x 15 cm2 cone, it takes 2.95 and 1.4 cm of Cerrobend to reduce the maximum block transmission to 5% and 10%, respectively. The maximum dose under a blocked electron beam occurs on the central axis closer to the surface than it does for the open beam, and the block transmission factor should be defined at this shallower depth. To decrease the block transmission factor to the level of 5% on the central axis, electron beams with energy 18 MeV and greater require additional shielding.

Electron beam treatment verification using measured and Monte Carlo predicted portal images

Electron beam treatments may benefit from techniques to verify patient positioning and dose delivery. This is particularly so for complex techniques such as mixed photon and electron beam radiotherapy and electron beam modulated therapy. This study demonstrates that it is possible to use the bremsstrahlung photons in an electron beam from a dual scattering foil linear accelerator to obtain portal images of electron beam treatments. The possibility of using Monte Carlo (MC) simulations to predict the electron beam treatment portal images was explored. The MC code EGSnrc was used to model a Varian CL21EX linear accelerator (linac) and to characterize the bremsstrahlung photon production in the linac head. It was found that the main sources of photons in the electron beam are the scattering foils, the applicator and the beam-shaping cut-out. Images were acquired using the Varian CL21EX linac and the Varian aS500 electronic portal imager (EPI); four electron energies (6, 9, 12, 16 MeV), and different applicator and cut-out sizes were used. It was possible to acquire images with as little as 10.7 MU per image. The contrast, the contrast-to-noise ratio (CNR), the signal-to-noise ratio (SNR), the resolution and an estimate of the modulated transfer function (MTF) of the electron beam portal images were computed using a quality assurance (QA) phantom and were found to be comparable to those of a 6 MV photon beam. Images were also acquired using a Rando anthropomorphic phantom. MC simulations were used to model the aS500 EPID and to obtain predicted portal images of the QA and Rando phantom. The contrast in simulated and measured portal images agrees within +/-5% for both the QA and the Rando phantom. The measured and simulated images allow for a verification of the phantom positioning by making sure that the structure edges are well aligned. This study suggests that the Varian aS500 portal imager can be used to obtain patient portal images of electron beams in the scattering foil linacs.

Transmission and dose perturbations with high-Z materials in clinical electron beams

High density and atomic number (Z) materials used in various prostheses, eye shielding, and beam modifiers produce dose enhancements on the backscatter side in electron beams and is well documented. However, on the transmission side the dose perturbation is given very little clinical importance, which is investigated in this study. A simple and accurate method for dose perturbation at metallic interfaces with soft tissues and transmission through these materials is required for all clinical electron beams. Measurements were taken with thin-window parallel plate ion chambers for various high-Z materials (Al, Ti, Cu, and Pb) on a Varian and a Siemens accelerator in the energy range of 5-20 MeV. The dose enhancement on both sides of the metallic sheet is due to increased electron fluence that is dependent on the beam energy and Z. On the transmission side, the magnitude of dose enhancement depends on the thickness of the high-Z material. With increasing thickness, dose perturbation reduces to the electron transmission. The thickness of material to reduce 100% (range of dose perturbation), 50% and 10% transmission is linear with the beam energy. The slope (mm/MeV) of the transmission curve varies exponentially with Z. A nonlinear regression expression (t=E[alpha+beta exp(-0.1Z)]) is derived to calculate the thickness at a given transmission, namely 100%, 50%, and 10% for electron energy, E, which is simple, accurate and well suited for a quick estimation in clinical use. Caution should be given to clinicians for the selection of thickness of high-Z materials when used to shield critical structures as small thickness increases dose significantly at interfaces.

Head scatter off-axis for megavoltage x rays

Our objective in this study has been to investigate how head scatter varies with the off-axis position in a 6 MV x-ray beam. We define the head-scatter off-axis ratio, HOA, as the ratio of the kerma due to head-scatter photons at the off-axis position x to the kerma from direct primary photons on the central axis. "Direct primary" are those photons that come from the source without interactions in the intervening structures. We determined HOA from measurements with an ionization chamber in a miniphantom. Head-scatter and direct primary photons contribute to a measurement of the ionization per mu Q(x) at the off-axis position x in the open field cx x cy. The ionization per mu QP(x), measured in the same position but with the field collimated to the smallest possible opening (cx x 3 cm), is intended to include only direct primary photons. Head-scatter photons cannot be completely eliminated, and the errors due to remaining head scatter and radiation back-scattered by the movable collimators into the monitor were estimated. For normalization of the final results, ionization due to direct primary photons was also measured on the central axis, QP(0). HOA was derived from these three measurements as HOA(cx,cy,x)=(Q(cx,cy,x) - QP(cx,cy,x))/QP(cx,cy,0). On the central axis (x=y=0), HOA represents the "scatter-to-primary ratio" between head scatter and the direct primary dose. Monte Carlo simulations were made to help with the interpretation and evaluation of the results. HOA could be fitted to a Gaussian model with two components corresponding to sources of widths 1.8 and 14 cm, projected on a plane 5 cm below the x-ray source. The narrow Gaussian component is interpreted as the source of photons scattered in the flattening filter and the primary collimator. The broad component is attributed to photons scattered in the secondary (variable) collimators. Conventional head-scatter models (e.g., a single Gaussian source model) do not fit the measured HOA data for large collimator settings (c>20 cm) or outside beam collimation. The full width at half-maximum (FWHM) of HOA(x) across the field increased with the field width (cx) in the direction of the measurements in a manner consistent with the field of view of the two sources. It was not sensitive to the field measure in the orthogonal direction (cy). Head scatter outside the field also increased with field size, reflecting an increased contribution of photons scattered at large angles. It exceeds the leakage through the collimator 2 cm outside the edge for square fields c>10 cm. Monte Carlo calculations showed considerably less head scatter outside the field than measurements.

Three-dimensional electron dose calculation using an improved hybrid pencil beam model

An improved hybrid-pencil beam model (HPBM) for electron-beam three-dimensional dose calculation has been studied. The model is based on the fact that away from the edges of a large field, the electron distribution function exactly equals that for an infinitely wide electron beam. In the present model, we use the bipartition model to calculate the longitudinal part of the pencil-beam distribution function, and Fermi-Eyges multiple-scattering theory to calculate its transverse part. In order to describe the electron beam characteristics accurately, we introduce a new parameter, which is extracted from measured profile data near the surface of a water phantom, to correct the transverse distribution determined by the Fermi-Eyges theory. Furthermore, we introduce an effective energy spectrum to describe the effect on the collimated electron beam of the accelerator head. The dose distributions calculated with the improved HPBM were compared with the experimental data, and the agreement was within 1% in most of cases. This preliminary study has demonstrated the potential for use of the model in the clinical therapy.

Dosimetry characteristics of degraded electron beams investigated by Monte Carlo calculations in a setup for intraoperative radiation therapy

Degraded electron beams, as used for intraoperative radiation therapy (IORT) or similar complicated dosimetric situations, have different characteristics compared to conventional electron therapy beams. If international dosimetry protocols are applied in a direct manner to such degraded beams, uncertainties will be introduced in the absorbed dose determination. The Monte Carlo method has been used to verify experimentally determined relative absorbed dose distributions and output factors in an IORT geometry. Monte Carlo generated dose distributions are mostly within +/-2% or +/-2 mm of measured data. The simulated output variation between the IORT cones (relative output factors) are mostly within 2% of measured values. By comparing IORT and conventional electron beam characteristics (e.g. energy spectra, angular distributions and the contributions of different system components to these quantities) limitations and uncertainties of commonly used dosimetric techniques in IORT electron fields are quantified. The intraoperative treatment field contains a larger amount of scattered electrons, which leads to a broader energy spectrum as well as a wider angular distribution of electrons at the phantom surface. The dose from the scattered electrons can contribute up to 40% of the total dose at a depth of dose maximum, compared to approximately 10% for standard beams. A study of the energy spectra at the reference depth reveals that an uncertainty of the order of 1% can be introduced if ionization chamber based dosimetry is used to determine output factors for the investigated IORT system. We recommend that relative absorbed dose distributions and output factors in IORT electron beams and for similar complicated dosimetric situations should be determined with detectors having a small energy and angular dependence (e.g. diamond detectors or p-Si diodes).